REG - GlaxoSmithKline PLC - Result of AGM

GSKAnnouncement

04/05/2022 18:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220504:nRSD3631Ka&default-theme=true

RNS Number : 3631K  GlaxoSmithKline PLC  04 May 2022

 

GlaxoSmithKline plc

 

Results of 22(nd) Annual General Meeting

 

GlaxoSmithKline plc ('GSK') held a hybrid Annual General Meeting ('AGM') at
2.30pm on Wednesday 4 May 2022. Shareholders were able to join virtually via
Lumi, Zoom and in person at the meeting held at the Sofitel Hotel in Terminal
5 Heathrow.

 

All valid proxy votes (whether submitted electronically or in hard copy form)
were included in the poll taken at the meeting.

 

The table below shows the results of the poll on all 28 resolutions. The full
text of the resolutions is contained in the Notice of AGM published on 28
March 2022, which is available on GSK's website at www.gsk.com
(http://www.gsk.com) .

 

 Resolution                                                                           Total votes for((1)(2))  %      Total votes against((2))  %      Total votes cast  Votes withheld((3))
 1       Receive and adopt the 2021 Annual Report                                     3,524,582,633            99.01  35,137,552                0.99   3,559,720,185     11,843,164
 2       Approve the Annual report on remuneration                                    3,240,737,115            91.05  318,510,405               8.95   3,559,247,520     12,317,062
 3       Approve the Remuneration Policy                                              2,197,755,545            61.76  1,360,515,540             38.24  3,558,271,085     13,294,793
 4       Election of Dr Anne Beal                                                     3,546,443,179            99.55  16,055,842                0.45   3,562,499,021     9,042,781
 5       Election of Dr Harry Dietz                                                   3,545,845,271            99.54  16,469,238                0.46   3,562,314,509     9,224,475
 6       Re-election of Sir Jonathan Symonds                                          3,482,374,837            97.76  79,898,313                2.24   3,562,273,150     9,274,730
 7       Re-election of Dame Emma Walmsley                                            3,555,195,651            99.79  7,564,971                 0.21   3,562,760,622     8,806,465
 8       Re-election of Charles Bancroft                                              3,503,934,446            98.36  58,393,472                1.64   3,562,327,918     9,214,474
 9       Re-election of Vindi Banga                                                   3,483,288,426            97.79  78,881,291                2.21   3,562,169,717     9,373,841
 10      Re-election of Dr Hal Barron                                                 3,546,018,185            99.54  16,347,031                0.46   3,562,365,216     9,173,855
 11      Re-election of Dr Vivienne Cox                                               3,531,865,048            99.14  30,474,324                0.86   3,562,339,372     9,204,548
 12      Re-election of Lynn Elsenhans                                                3,476,281,291            97.58  86,142,909                2.42   3,562,424,200     9,118,541
 13      Re-election of Dr Laurie Glimcher                                            3,556,622,114            99.84  5,547,225                 0.16   3,562,169,339     9,375,696
 14      Re-election of Dr Jesse Goodman                                              3,555,655,121            99.82  6,515,409                 0.18   3,562,170,530     9,367,820
 15      Re-election of Iain Mackay                                                   3,551,784,186            99.71  10,432,989                0.29   3,562,217,175     9,333,434
 16      Re-election of Urs Rohner                                                    3,410,175,068            95.74  151,806,419               4.26   3,561,981,487     9,561,680
 17      Re-appointment of the auditor                                                3,557,280,686            99.84  5,797,033                 0.16   3,563,077,719     8,481,780
 18      Remuneration of the auditor                                                  3,555,233,064            99.86  5,000,395                 0.14   3,560,233,459     11,338,880
 19      Authority for the company to make donations to political organisations and   3,493,409,287            98.64  48,161,797                1.36   3,541,571,084     30,003,446
         incur political expenditure
 20      Authority to allot shares                                                    3,430,993,149            96.35  130,127,471               3.65   3,561,120,620     10,593,875
 21      Disapplication of pre-emption rights - general power((4))                    3,460,375,320            97.24  98,220,644                2.76   3,558,595,964     12,963,416
 22      Disapplication of pre-emption rights - in connection with an acquisition or  3,404,168,390            95.65  154,942,194               4.35   3,559,110,584     12,448,092
         specified capital investment((4))
 23      Authority for the company to purchase its own shares((4))                    3,517,497,794            98.79  43,085,674                1.21   3,560,583,468     10,990,502
 24      Exemption from statement of senior statutory auditor's name                  3,523,554,816            99.59  14,359,955                0.41   3,537,914,771     33,655,391
 25      Authority for reduced notice of a general meeting other than an AGM((4))     3,331,432,180            93.62  227,176,994               6.38   3,558,609,174     12,950,914
 26      Approve the Share Save Plan 2022                                             3,508,449,940            98.62  49,235,709                1.38   3,557,685,649     13,896,262
 27      Approve the Share Reward Plan 2022                                           3,516,666,377            98.86  40,690,090                1.14   3,557,356,467     14,160,284
 28      Approve the adoption of new Articles of Association((4))                     3,549,030,121            99.80  6,964,097                 0.20   3,555,994,218     15,501,889

 

Resolution 3 - Approval of the Remuneration Policy

 

The Company was pleased that the new remuneration policy was supported in a
vote at today's Annual General Meeting.  It also notes that a significant
minority were not able to support the new policy at this time. The Company
undertook an in-depth consultation process with the majority of its largest
shareholders in developing the revised policy and will continue to engage to
ensure it fully understands the views of all shareholders on these matters,
and to continue to explain the rationale for the changes.

 

Notes:

 

(1)   The "for" votes include those giving the Chair discretion. In line
with the notification issued to American Depositary Receipt (ADR) holders last
year, GSK did not instruct its ADR Depositary to vote any unvoted ADRs in
respect of the AGM resolutions.

(2)      Votes "for" and "against" are expressed as a percentage of the
total votes cast.

(3)     A vote withheld is not a vote in law and is not counted in the
calculation of the proportion of votes "for" or "against" a resolution.

(4)      Indicates Special Resolutions requiring a 75% majority.

 

The following table provides further information on participation in the AGM:

                                                                          GSK's                       GSK's

                                                                          Twenty second               Twenty first

                                                                          AGM                         AGM

                                                                          (Hybrid meeting)            (Virtual meeting)

                                                                          (2022)                      (2021)
 Issued share capital (excluding Treasury Shares)                         5,083,974,547               5,031,444,276
 Total votes cast and votes withheld lodged as a % of GSK's issued share  70.25%                      70.11%
 capital (excluding Treasury Shares)
 Total shareholder population                                             89,764                      100,906
 Total number of proxies lodged                                           5,343                       6,089
 Number of shareholders in attendance                                     93 in person                142 participated virtually

                                                                          68 participated virtually
 % of shareholders who lodged proxies                                     5.95%                       6.03%

 

The above poll results will shortly be available on the company's website at
www.gsk.com (http://www.gsk.com) . In accordance with Listing Rule 9.6.2, a
copy of the resolutions, other than those concerning ordinary business, will
be submitted to the UK Listing Authority and will in due course be available
for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism)

 

V A Whyte

Company Secretary

4 May 2022

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGBKQBQABKDAPK